88 related articles for article (PubMed ID: 27297429)
21. Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study.
Saadatian-Elahi M; Toniolo P; Ferrari P; Goudable J; Akhmedkhanov A; Zeleniuch-Jacquotte A; Riboli E
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1353-60. PubMed ID: 12433711
[TBL] [Abstract][Full Text] [Related]
22. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence.
Astorg P
Cancer Causes Control; 2004 May; 15(4):367-86. PubMed ID: 15141138
[TBL] [Abstract][Full Text] [Related]
23. The association of plasma fatty acids with prostate cancer risk in Nigerians.
Ukoli FA; Akumabor PN; Oguike TC; Dent LL; Beech D; Osime U
Ethn Dis; 2009; 19(4):454-61. PubMed ID: 20073148
[TBL] [Abstract][Full Text] [Related]
24. Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant.
Liu X; Schumacher FR; Plummer SJ; Jorgenson E; Casey G; Witte JS
Carcinogenesis; 2007 Jun; 28(6):1232-6. PubMed ID: 17234723
[TBL] [Abstract][Full Text] [Related]
25. Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial.
King IB; Kristal AR; Schaffer S; Thornquist M; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):988-92. PubMed ID: 15824175
[TBL] [Abstract][Full Text] [Related]
26. Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study.
Marangoni F; Novo G; Perna G; Perrone Filardi P; Pirelli S; Ceroti M; Querci A; Poli A
Atherosclerosis; 2014 Feb; 232(2):334-8. PubMed ID: 24468146
[TBL] [Abstract][Full Text] [Related]
27. Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.
Schuurman AG; van den Brandt PA; Dorant E; Brants HA; Goldbohm RA
Cancer; 1999 Sep; 86(6):1019-27. PubMed ID: 10491529
[TBL] [Abstract][Full Text] [Related]
28. Is fatty acid intake a predictor of arterial stiffness and blood pressure in men? Evidence from the Caerphilly Prospective Study.
Livingstone KM; Givens DI; Cockcroft JR; Pickering JE; Lovegrove JA
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1079-85. PubMed ID: 23415455
[TBL] [Abstract][Full Text] [Related]
29. Assessing the effect of fatty acids on prostate carcinogenesis in humans: does self-reported dietary intake rank prostatic exposure correctly?
Freeman VL; Meydani M; Yong S; Pyle J; Durazo-Arvizu R; Liao Y; Flanigan RC; Waters WB
Am J Clin Nutr; 2001 Apr; 73(4):815-20. PubMed ID: 11273858
[TBL] [Abstract][Full Text] [Related]
30. N-6 and n-3 fatty acid cholesteryl esters in relation to incident stroke in a Dutch adult population: a nested case-control study.
De Goede J; Verschuren WM; Boer JM; Kromhout D; Geleijnse JM
Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):737-43. PubMed ID: 22633188
[TBL] [Abstract][Full Text] [Related]
31. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
32. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
33. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
[TBL] [Abstract][Full Text] [Related]
34. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
35. No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Stevens VL; Jacobs EJ; Sun J; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):890-2. PubMed ID: 24585409
[TBL] [Abstract][Full Text] [Related]
36. A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden).
Wallström P; Bjartell A; Gullberg B; Olsson H; Wirfält E
Cancer Causes Control; 2007 Dec; 18(10):1107-21. PubMed ID: 17726648
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of intake of fish and marine fatty acids and prostate cancer.
Augustsson K; Michaud DS; Rimm EB; Leitzmann MF; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):64-7. PubMed ID: 12540506
[TBL] [Abstract][Full Text] [Related]
38. Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health Study.
Delgado GE; Krämer BK; Lorkowski S; März W; von Schacky C; Kleber ME
J Clin Lipidol; 2017; 11(1):126-135.e5. PubMed ID: 28391879
[TBL] [Abstract][Full Text] [Related]
39. The association of fatty acids with prostate cancer risk.
Newcomer LM; King IB; Wicklund KG; Stanford JL
Prostate; 2001 Jun; 47(4):262-8. PubMed ID: 11398173
[TBL] [Abstract][Full Text] [Related]
40. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
